Mr. Martin LeBlanc has led the development of proteomics technology and services at Caprion by estab-lishing revenue-generating biomarker-and-therapeutic-target-discovery alliances with over 30 major pharmaceutical and biotech companies.

Related Articles

• Medicine 2020:Portable, personalized, informed (June 2010)